Celon Pharma S.A. (WSE:CLN)
Poland flag Poland · Delayed Price · Currency is PLN
20.75
-0.15 (-0.72%)
Aug 14, 2026, 5:00 PM CET

Celon Pharma Market Cap

Celon Pharma has a market cap or net worth of 1.12 billion as of August 14, 2026. Its market cap has decreased by -10.17% in one year.

Market Cap
1.12B
Enterprise Value
1.16B
Revenue
254.41M
Ranking
n/a
PE Ratio
10.18
Stock Price
20.75

Chart

Chart

Since December 1, 2016, Celon Pharma's market cap has increased from 1.00B to 1.12B, an increase of 11.46%. That is a compound annual growth rate of 1.12%.

History

DateMarket Cap% Change
Aug 14, 20261.12B1.97%
Dec 30, 20251.10B-23.06%
Dec 30, 20241.42B80.47%
Dec 29, 2023789.33M10.32%
Dec 30, 2022715.51M-57.68%
Dec 30, 20211.69B-7.35%
Dec 30, 2020 Pro Pro
Dec 30, 2019 Pro Pro
Dec 28, 2018 Pro Pro
Dec 29, 2017 Pro Pro
Dec 30, 2016 Pro Pro
Dec 1, 2016 Pro Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Related Stocks

CompanyMarket Cap
Diagnostyka5.70B
NEUCA3.49B
Synektik Spólka Akcyjna3.07B
Voxel1.35B
Medinice652.85M
Syn2bio575.25M
Centrum Medyczne ENEL-MED562.78M
Selvita523.13M
Market Cap Rankings